An interventional study of tea catechin extracts in Influenza Infection, sponsored by University of Shizuoka. Completed at 2 sites in Japan. Open to participants aged 20 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-11-26.
Sponsored by University of Shizuoka · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Influenza, Human with a site in Japan — 4 open to participants now, 4 under way, 3 of them phase 3. Influenza, Human · Japan.
Among the 42 studies in Influenza, Human with a site in Japan, this one is the 19th largest by enrollment of the 40 interventional ones that give a count, is one of 3 that started in 2008, is one of 5 with no phase, and was the 4th registered.
2,361 studies on the registry are indexed under Influenza, Human; 186 are open to participants now.
Browse Influenza, Human studies →4 of the 42 studies in Influenza, Human with a site in Japan are open now. Recruiting first, the newest first:
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · Sites in Japan, United States, Argentina and 3 more countries
Ages 12+
AstraZeneca · Sites in Japan, United States, Argentina and 36 more countries
Ages 18+
UMC Utrecht · Sites in Japan, United States, Australia and 26 more countries
Ages 28 days+
Chiba University · Sites in Japan
Ages 20–49 · Healthy volunteers
A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →
Of the 124 Influenza, Human studies recruiting now, 67 (54%) set no upper age limit and 47 (38%) stop at 75 or younger; 34 take children under 18; 69 take healthy volunteers.
This study: 20 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 12 · Phase 3 18 · Phase 4 4
First in 2005; this study’s year is marked. 3 started in 2008.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 180 is below the median of 228 across 1,959 interventional studies indexed under Influenza, Human.
Median enrollment 169 across the 40 interventional studies, 6,138 across the 2 observational. Of the 35 that completed or were terminated, 15 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 42 have an industry lead sponsor. The 10 most frequent:
University of Shizuoka is the lead sponsor of 11 studies on the registry; 1 is open to participants now.
University of Shizuoka has 3 studies filed under Influenza, Human — fewer than ten, so there is no comparison to draw.
3 of the studies in Influenza, Human with a site in Japan that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07159763Phase 3Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06) | 2027-07-02 |
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT07739446Chiba UniversityEffect of Surgical Masks in Preventing Acute Respiratory Infections | 2027-03 |
Add all 3 to your calendar (.ics) → With an account.
Among the 42 studies in Influenza, Human with a site in Japan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the effects of catechin extracts containing mask on prevention of influenza infection.
Catechins are the major components of tea flavonoids and are reported to possess physiological activities such as antiviral effects. Recent in-vitro experimental studies have revealed that tea catechin extracts possess the effects on the prevention of influenza infection. However, a limited number of studies have been conducted on the clinical effects. Based on these backgrounds, we designed a prospective randomized controlled study to evaluate the effects of tea catechin extracts containing mask on the prevention of influenza infection.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
wearing the tea catechin extracts containing mask
Dietary Supplement: tea catechin extracts
catechins are composed of tea catechin extracts available in grren tea supplements
the incidence rate of influenza infection during the study
Time frame: assessed at each month
the incidence rates of upper respiratory tract infections
Time frame: assessed at each month
the severity of the symptoms and the duration of the cold among incident cases
Time frame: assessed at each month
he incidence-free time for influenza or upper respiratory tract infections after the intervention
Time frame: assessed at each month
The record gives a start of Dec 2008, a primary completion of Nov 2009 and a completion of Nov 2009. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Shizuoka